Olive Oil Polyphenols Improve HDL Cholesterol and Promote Maintenance of Lipid Metabolism: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Open accessThe DOI matches its Crossref record; 57 of the 58 references it cites were found in a registry or an index; 11 of the 30 sources its claims cite were checked for support.
Abstract
Systematic review and meta-analysis of randomized controlled trials evaluating olive oil polyphenols and serum lipid outcomes in adults.
Overview
CoChat Summary
TL;DR
This systematic review and meta-analysis of 10 randomized controlled trials found that olive oil polyphenols significantly increased HDL-C and, at high daily exposure, reduced LDL-C, while having no significant effect on total cholesterol. The authors conclude that olive oil polyphenols may help maintain lipid metabolism and could support stronger food-labeling claims.
Key findings
- The review included 10 RCTs after screening 152 records; the final evidence base covered 991 participants for HDL-C and LDL-C analyses and 969 for TC.
- Daily olive oil polyphenol consumption had no significant effect on total cholesterol: WMD 0.49, 95% CI −0.55 to 1.53, heterogeneity 14%, p = 0.28.
- HDL-C increased significantly overall: WMD 1.13, 95% CI 0.45 to 1.80, heterogeneity 38%, p = 0.04; effects were significant at low (WMD 0.66, 95% CI 0.10–1.23), medium (WMD 1.36, 95% CI 0.76–1.95), and high (WMD 1.13, 95% CI 0.45–1.80) exposure levels.
- LDL-C decreased slightly overall: WMD −0.83, 95% CI −1.67 to 0.01, heterogeneity 73%, p < 0.01; the strongest reduction was at high exposure (268–600 mg/kg): WMD −4.28, 95% CI −5.78 to −2.77.
Methods
- Systematic review and meta-analysis of human randomized controlled trials, following PRISMA and registered in PROSPERO (CRD42023403383).
- Searched PubMed, MEDLINE, EMBASE, Scopus, Ovid, Google Scholar, plus gray literature sources, up to 1 July 2023; included adult RCTs with crossover or parallel design reporting at least three lipid outcomes (HDL-C, LDL-C, TC) and intake of at least 20 g/day olive oil.
- Used duplicate screening/data extraction and RoB-2 quality assessment; pooled weighted mean differences with 95% CIs were analyzed in R, with subgroup meta-analyses by daily olive oil polyphenol exposure tertiles.
Limitations
- Stated by the paper: the authors note heterogeneity from not differentiating olive oil cultivars/types, population differences (2 of 10 RCTs were non-European), slight design differences, inconsistent intervention washout periods, and study power not always being justified.
- Also evident from the text: only 10 RCTs were included, only 4 were double-blind, and some outcomes showed substantial heterogeneity, especially LDL-C (I2 = 73%).
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
7 Valid · 0 Not valid · 7 Not checked · 14 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“Previous research has shown that oleuropein is a ligand of peroxisome proliferator-activated receptor-alpha (PPAR-α) [48].”
§ Olive Oil Polyphenols Improve HDL Cholesterol and Promote Maintenance of Lipid Metabolism: A Systematic Review and Meta-Analysis of Randomized Controlled Trials > 4. Discussion
What the sources say
- Supportedcites [48] Malliou, 2018, The Olive Constituent Oleuropein, as a PPARα Agonist, Markedly Reduces Serum Triglycerides, J. Nutr. Biochem. source
The Results section (‘Assessment of OLE binding to PPARα’) explicitly concludes from the reporter gene assay that oleuropein acts as a PPARα ligand. The Discussion says the molecular docking findings support the same conclusion. (LLM, conf=0.95)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Further, oleuropein was shown to decrease the activity of hydroxymethylglutaryl-CoA reductase, which led to a reduction in cholesterol synthesis in rat hepatocytes [18,50].”
§ Olive Oil Polyphenols Improve HDL Cholesterol and Promote Maintenance of Lipid Metabolism: A Systematic Review and Meta-Analysis of Randomized Controlled Trials > 4. Discussion
What the sources say
- Partly supportedcites [18] Lammi, C., Bellumori, M., Cecchi, L., Bartolomei, M., Bollati, C., Clodoveo, M.L., Corbo, F., Arnoldi, A., and Mulinacci, N. (2020). Extra Virgin Olive Oil Phenol Extracts Exert Hypocholesterolemic Effects through the Modulation of the LDLR Pathway: In Vitro and Cellular Mechanism of Action Elucidation. Nutrients, 12. sourceExperimental — accuracy not yet measured
The Results (§3.2 and §3.5) report that extra-virgin olive oil phenol extracts inhibit HMG-CoA reductase and affect its regulation in HepG2 cells. The Discussion (§4) only suggests that derivatives of oleuropein and ligstroside may be responsible; it does not establish an effect of oleuropein alone or reduced cholesterol synthesis in rat hepatocytes. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [50] Priore, 2014, Extra Virgin Olive Oil Phenols down-Regulate Lipid Synthesis in Primary-Cultured Rat-Hepatocytes, J. Nutr. Biochem. source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“when HDL-C was the considered outcome, the daily consumption of olive oil polyphenols showed a statistically significant effect on enhancing HDL-C levels in a total sample of 991 subjects (WMD common effect model 1.13, 95%CI 0.45; 1.80, heterogeneity 38%, p = 0.04)”
- Also stated in: § Abstract In 2011, the European Food Safety Authority (EFSA) accorded a health claim to olive oil polyphenols in that they protected LDL particles from oxidative damage. However, limited scientific evidence has so far failed to confer any claim of function on the maintenance of normal lipid metabolism. We performed a systematic review and meta-analysis of human RCTs, evaluating the effect of olive oil polyphenol administration on lipid profiles. Previous literature was acquired from six electronic databases until June 2023. A total of 75 articles were retrieved and screened for inclusion criteria, which resulted in the selection of 10 RCTs that evaluated the effect of daily exposure to olive oil polyphenols on serum lipids in adults. Meta-analyses were built by tertiles of outcomes, as follows: low (0–68 mg/kg), medium (68–320 mg/kg), and high (320–600 mg/kg) polyphenols for HDL and LDL cholesterol (HDL-C and LDL-C, respectively), and low (0–59.3 mg/kg), medium (59.3–268 mg/kg), and high (268–600 mg/kg) polyphenols for total cholesterol (TC). The study protocol was registered on PROSPERO (registration code: CRD42023403383). The study design was predominantly cross-over (n = 8 of 10) but also included parallel (n = 2 of 10). The study population was predominantly European and healthy. Daily consumption of olive oil polyphenols did not affect TC levels and only slightly significantly reduced LDL-C, with WMD statistically significant only for high daily consumption of olive oil polyphenols (WMD −4.28, 95%CI −5.78 to −2.77). Instead, our data found a statistically significant HDL-C enhancing effect (WMD pooled effect model: 1.13, 95%CI 0.45; 1.80, heterogeneity 38%, p = 0.04) with WMD by daily exposure level showing a statistically significant improvement effect for low (WMD 0.66, 95%CI 0.10–1.23), medium (WMD 1.36, 95%CI 0.76–1.95), and high (WMD 1.13, 95%CI 0.45–1.80) olive oil polyphenol consumptions. Olive oil polyphenols contribute toward maintaining lipid metabolism. Thus, food labeling regulations should stress this health feature of olive oil, whereby a declaration of the olive oil polyphenol content should be added to products on the market. Consumers need to be aware of the quality and possible health effects of any products they consume, and enforcement of nutrition labels offers the best way of providing this information. · plain
“our data found a statistically significant HDL-C enhancing effect (WMD pooled effect model: 1.13, 95%CI 0.45; 1.80, heterogeneity 38%, p = 0.04)”
§ Olive Oil Polyphenols Improve HDL Cholesterol and Promote Maintenance of Lipid Metabolism: A Systematic Review and Meta-Analysis of Randomized Controlled Trials > 3. Results
plainstates a causen = 991 ·- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Abstract In 2011, the European Food Safety Authority (EFSA) accorded a health claim to olive oil polyphenols in that they protected LDL particles from oxidative damage. However, limited scientific evidence has so far failed to confer any claim of function on the maintenance of normal lipid metabolism. We performed a systematic review and meta-analysis of human RCTs, evaluating the effect of olive oil polyphenol administration on lipid profiles. Previous literature was acquired from six electronic databases until June 2023. A total of 75 articles were retrieved and screened for inclusion criteria, which resulted in the selection of 10 RCTs that evaluated the effect of daily exposure to olive oil polyphenols on serum lipids in adults. Meta-analyses were built by tertiles of outcomes, as follows: low (0–68 mg/kg), medium (68–320 mg/kg), and high (320–600 mg/kg) polyphenols for HDL and LDL cholesterol (HDL-C and LDL-C, respectively), and low (0–59.3 mg/kg), medium (59.3–268 mg/kg), and high (268–600 mg/kg) polyphenols for total cholesterol (TC). The study protocol was registered on PROSPERO (registration code: CRD42023403383). The study design was predominantly cross-over (n = 8 of 10) but also included parallel (n = 2 of 10). The study population was predominantly European and healthy. Daily consumption of olive oil polyphenols did not affect TC levels and only slightly significantly reduced LDL-C, with WMD statistically significant only for high daily consumption of olive oil polyphenols (WMD −4.28, 95%CI −5.78 to −2.77). Instead, our data found a statistically significant HDL-C enhancing effect (WMD pooled effect model: 1.13, 95%CI 0.45; 1.80, heterogeneity 38%, p = 0.04) with WMD by daily exposure level showing a statistically significant improvement effect for low (WMD 0.66, 95%CI 0.10–1.23), medium (WMD 1.36, 95%CI 0.76–1.95), and high (WMD 1.13, 95%CI 0.45–1.80) olive oil polyphenol consumptions. Olive oil polyphenols contribute toward maintaining lipid metabolism. Thus, food labeling regulations should stress this health feature of olive oil, whereby a declaration of the olive oil polyphenol content should be added to products on the market. Consumers need to be aware of the quality and possible health effects of any products they consume, and enforcement of nutrition labels offers the best way of providing this information. · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“When LDL-C was considered as the outcome, daily consumption of olive oil polyphenols slightly but significantly reduced LDL-C levels in a total sample of 991 people (WMDs common effect model −0.83, 95%CI −1.67 to 0.01, heterogeneity 73%, p < 0.01)”
- Also stated in: § 4. Discussion · plain
“However, when LDL-C was targeted, the daily consumption of olive oil polyphenols slightly but significantly reduced LDL-C levels in a total sample of 991 people (WMDs common effect model −0.83, 95%CI −1.67 to 0.01, heterogeneity 73%, p < 0.01)”
§ Olive Oil Polyphenols Improve HDL Cholesterol and Promote Maintenance of Lipid Metabolism: A Systematic Review and Meta-Analysis of Randomized Controlled Trials > 3. Results
plainstates a causen = 991 ·- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § 4. Discussion · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“WMDs for each level of daily exposure showed a strong significant effect on reducing LDL-C levels, yet only in individuals participating in a daily high consumption of olive oil polyphenols (WMD −4.28, 95%CI −5.78 to −2.77).”
- Also stated in: § Abstract In 2011, the European Food Safety Authority (EFSA) accorded a health claim to olive oil polyphenols in that they protected LDL particles from oxidative damage. However, limited scientific evidence has so far failed to confer any claim of function on the maintenance of normal lipid metabolism. We performed a systematic review and meta-analysis of human RCTs, evaluating the effect of olive oil polyphenol administration on lipid profiles. Previous literature was acquired from six electronic databases until June 2023. A total of 75 articles were retrieved and screened for inclusion criteria, which resulted in the selection of 10 RCTs that evaluated the effect of daily exposure to olive oil polyphenols on serum lipids in adults. Meta-analyses were built by tertiles of outcomes, as follows: low (0–68 mg/kg), medium (68–320 mg/kg), and high (320–600 mg/kg) polyphenols for HDL and LDL cholesterol (HDL-C and LDL-C, respectively), and low (0–59.3 mg/kg), medium (59.3–268 mg/kg), and high (268–600 mg/kg) polyphenols for total cholesterol (TC). The study protocol was registered on PROSPERO (registration code: CRD42023403383). The study design was predominantly cross-over (n = 8 of 10) but also included parallel (n = 2 of 10). The study population was predominantly European and healthy. Daily consumption of olive oil polyphenols did not affect TC levels and only slightly significantly reduced LDL-C, with WMD statistically significant only for high daily consumption of olive oil polyphenols (WMD −4.28, 95%CI −5.78 to −2.77). Instead, our data found a statistically significant HDL-C enhancing effect (WMD pooled effect model: 1.13, 95%CI 0.45; 1.80, heterogeneity 38%, p = 0.04) with WMD by daily exposure level showing a statistically significant improvement effect for low (WMD 0.66, 95%CI 0.10–1.23), medium (WMD 1.36, 95%CI 0.76–1.95), and high (WMD 1.13, 95%CI 0.45–1.80) olive oil polyphenol consumptions. Olive oil polyphenols contribute toward maintaining lipid metabolism. Thus, food labeling regulations should stress this health feature of olive oil, whereby a declaration of the olive oil polyphenol content should be added to products on the market. Consumers need to be aware of the quality and possible health effects of any products they consume, and enforcement of nutrition labels offers the best way of providing this information. · plain
“only slightly significantly reduced LDL-C, with WMD statistically significant only for high daily consumption of olive oil polyphenols (WMD −4.28, 95%CI −5.78 to −2.77).”
§ Olive Oil Polyphenols Improve HDL Cholesterol and Promote Maintenance of Lipid Metabolism: A Systematic Review and Meta-Analysis of Randomized Controlled Trials > 3. Results
boostedstates a causen = 991 ·- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Abstract In 2011, the European Food Safety Authority (EFSA) accorded a health claim to olive oil polyphenols in that they protected LDL particles from oxidative damage. However, limited scientific evidence has so far failed to confer any claim of function on the maintenance of normal lipid metabolism. We performed a systematic review and meta-analysis of human RCTs, evaluating the effect of olive oil polyphenol administration on lipid profiles. Previous literature was acquired from six electronic databases until June 2023. A total of 75 articles were retrieved and screened for inclusion criteria, which resulted in the selection of 10 RCTs that evaluated the effect of daily exposure to olive oil polyphenols on serum lipids in adults. Meta-analyses were built by tertiles of outcomes, as follows: low (0–68 mg/kg), medium (68–320 mg/kg), and high (320–600 mg/kg) polyphenols for HDL and LDL cholesterol (HDL-C and LDL-C, respectively), and low (0–59.3 mg/kg), medium (59.3–268 mg/kg), and high (268–600 mg/kg) polyphenols for total cholesterol (TC). The study protocol was registered on PROSPERO (registration code: CRD42023403383). The study design was predominantly cross-over (n = 8 of 10) but also included parallel (n = 2 of 10). The study population was predominantly European and healthy. Daily consumption of olive oil polyphenols did not affect TC levels and only slightly significantly reduced LDL-C, with WMD statistically significant only for high daily consumption of olive oil polyphenols (WMD −4.28, 95%CI −5.78 to −2.77). Instead, our data found a statistically significant HDL-C enhancing effect (WMD pooled effect model: 1.13, 95%CI 0.45; 1.80, heterogeneity 38%, p = 0.04) with WMD by daily exposure level showing a statistically significant improvement effect for low (WMD 0.66, 95%CI 0.10–1.23), medium (WMD 1.36, 95%CI 0.76–1.95), and high (WMD 1.13, 95%CI 0.45–1.80) olive oil polyphenol consumptions. Olive oil polyphenols contribute toward maintaining lipid metabolism. Thus, food labeling regulations should stress this health feature of olive oil, whereby a declaration of the olive oil polyphenol content should be added to products on the market. Consumers need to be aware of the quality and possible health effects of any products they consume, and enforcement of nutrition labels offers the best way of providing this information. · plain
8 more claims
Create a free account to see all 28 claims and to verify the 1 reference still open.
- Probably not a substantial claim. 11
- It may state two separate claims as one. 10
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Olive Oil Polyphenols Improve HDL Cholesterol and Promote Maintenance of Lipid Metabolism: A Systematic Review and Meta-Analysis of Randomized Controlled Trials > 3. Results
“four weeks being used in two studies [34,39], three months in one study [37], and four days in another [39,40].”
§ Olive Oil Polyphenols Improve HDL Cholesterol and Promote Maintenance of Lipid Metabolism: A Systematic Review and Meta-Analysis of Randomized Controlled Trials > 3. Results
“four weeks being used in two studies [34,39], three months in one study [37], and four days in another [39,40].”
Citations
Cites
RoB 2: a revised tool for assessing risk of bias in randomised trials
Sterne, J. A. C., Savović, J., Page, M. J., Elbers, R. G., Blencowe, N. S., Boutron, I., Cates, C. J., Cheng, H.-Y., Corbett, M. S., Eldridge, S. M., et al. (2019) · BMJ · doi:10.1136/bmj.l4898 · Cited by 34,787 · cited 1×
“Final judgments and overall risk of bias were defined as “low” or “high” risk of bias or expressed as “some concerns” [29].”
Page, M. J., Moher, D., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · BMJ · doi:10.1136/bmj.n160 · Cited by 13,262 · cited 1×
“The present systematic review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, adhering to the PRISMA 27-item checklist [27].”
MethodBorenstein, M., Hedges, L. V., Higgins, J. P. T., & Rothstein, H. R. (2021) · doi:10.1002/9781119558378 · Cited by 9,799
The Global Burden of Cardiovascular Diseases and Risk
Vaduganathan, M., Mensah, G. A., Turco, J. V., Fuster, V., & Roth, G. A. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.11.005 · Cited by 2,217 · cited 1×
“In 2021, 17.9 million deaths, or 33% of all global deaths, were attributed to CVD, including 7.4 million due to coronary heart disease (CHD) and 6.7 million from stroke [1].”
BackgroundInfluentialThe Effect of Mediterranean Diet on Metabolic Syndrome and its Components
Kastorini, C.-M., Milionis, H. J., Esposito, K., Giugliano, D., Goudevenos, J. A., & Panagiotakos, D. B. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.09.073 · Cited by 1,087 · cited 3×
“Since modifiable lifestyle factors prevent cardiovascular risk, the Mediterranean diet has drawn extensive attention over recent decades for its beneficial effects on cardiometabolic and cardiovascular health [3,8,9].”
BackgroundThe Effect of Polyphenols in Olive Oil on Heart Disease Risk Factors: A Randomized Trial
Covas, M.-I., Nyyssönen, K., Poulsen, H. E., Kaikkonen, J., Zunft, H.-J. F., Kiesewetter, H., Gaddi, A., de la Torre, R., Mursu, J., Bäumler, H., et al. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-5-200609050-00006 · Cited by 758 · cited 3×
“Interestingly, a 2006 multicenter report by Covas et al. demonstrated a linear increase in HDL cholesterol levels in 200 healthy males following the administration of olive oils containing low, medium, and high polyphenol contents for 3 weeks [38].”
BackgroundAntioxidant and other biological activities of phenols from olives and olive oil
Visioli, F., Poli, A., & Gall, C. (2002) · Medicinal Research Reviews · doi:10.1002/med.1028 · Cited by 754 · cited 1×
“…evidence has currently demonstrated that phenolic compounds, particularly hydroxytyrosol and oleuropein, may dose-dependently inhibit LDL and HDL oxidation both in vitro and in vivo, while also repressing superoxide-driven reactions, and disrupting the chain propagation of lipid peroxides [42,43].”
BackgroundBelur, J., Tompson, L., Thornton, A., & Simon, M. (2021) · Sociological Methods & Research · doi:10.1177/0049124118799372 · Cited by 753 · cited 1×
“According to PRISMA concepts and the quality assessment steps, a coefficient k of at least 0.9 was obtained in all data extraction steps [28].”
MethodInfluentialAntimicrobial, antioxidant and anti-inflammatory phenolic activities in extra virgin olive oil
Cicerale, S., Lucas, L., & Keast, R. (2012) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2011.09.006 · Cited by 468
Polyphenols, Inflammation, and Cardiovascular Disease
Tangney, C. C., & Rasmussen, H. E. (2013) · Current Atherosclerosis Reports · doi:10.1007/s11883-013-0324-x · Cited by 340
Research works printed but not linked: 2
- Perez-Martinez, P., Perez-Jimenez, F., and Lopez-Miranda, J. (2010). Olives and Olive Oil in Health and Disease Prevention, Academic Press.
- Amirante, P., Clodoveo, M.L., Tamborrino, A., Leone, A., and Paice, A.G. (2010). Olives and Olive Oil in Health and Disease Prevention, Academic Press.
Cited by
Sualeheen, A., Tan, S., Georgousopoulou, E. N., Daly, R. M., Tierney, A. C., Roberts, S. K., & George, E. S. (2024) · Nutrition Bulletin · doi:10.1111/nbu.12707 · Cited by 41
Nutraceuticals and Functional Foods: A Comprehensive Review of Their Role in Bone Health
Faienza, M. F., Giardinelli, S., Annicchiarico, A., Chiarito, M., Barile, B., Corbo, F., & Brunetti, G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25115873 · Cited by 51
“In a cohort of 523 women, people who declared in an FFQ a higher dietary intake of olive oil (>18.32 g/day) had significantly higher volumetric bone mineral density (vBMD, p 0.01), total, trabecular, and cortical bone density compared with those with a lower intake of olive oil [229].”
BackgroundInfluentialSelf-citationTherapeutic Potential of Olive Leaf Extracts: A Comprehensive Review
de Oliveira, N. M., Machado, J. P., Chéu, M. H., Lopes, L. T., & Criado, M. B. (2024) · Applied Biosciences · doi:10.3390/applbiosci3030026 · Cited by 43
“…et al., 2024, OLE phenolic composites drop their bioavailability after digestion [236] and so, the antibacterial and antioxidant power of OLE are compromised after gastrointestinal digestion because an incomplete intestinal absorption allied to a quick elimination through urinary excretion [237].”
Health Outcomes Associated with Olive Oil Intake: An Umbrella Review of Meta-Analyses
Chiavarini, M., Rosignoli, P., Giacchetta, I., & Fabiani, R. (2024) · Foods · doi:10.3390/foods13162619 · Cited by 36
“…the association between cardiovascular risk or disease and olive oil [4,47,50–61,67–70 Seven articles described the association between cancer and olive oil consumption [61–66], twenty articles investigated the association between cardiovascular risk or disease and olive oil [4,47,50–61,67”
BackgroundInfluentialDietary Intake of Polyphenols and All-Cause Mortality: A Systematic Review with Meta-Analysis
Zupo, R., Castellana, F., Lisco, G., Corbo, F., Crupi, P., Sardone, R., Panza, F., Lozupone, M., Rondanelli, M., & Clodoveo, M. L. (2024) · Metabolites · doi:10.3390/metabo14080404 · Cited by 17
“Bromatologically, the MedDiet is greatly rich in mono-and polyunsaturated fatty acids [8] and also polyphenols, which are bioactive compounds found mainly in plant foods and plant-derived beverages, such as coffee, tea, and red wine [9,10].”
BackgroundSelf-citation
Metadata
- Authors
- Zupo, R., Castellana, F., Crupi, P., Desantis, A., Rondanelli, M., Corbo, F., & Clodoveo, M. L.
- Affiliations
- University of Bari Aldo Moro (IT)
- University of Pavia (IT)
- Corresponding author
- Zupo, Roberta
- ORCID
- Venue
- Metabolites
- Publisher
- MDPI AG
- Published
- 2023-12-06
- Volume
- 13
- Issue
- 12
- Pages
- 1187
- ISSN
- 2218-1989 (ISSN-L)
- PMC
- PMC10745457
- OpenAlex
- W4389379824
- Cited by
- 30
- References
- 58
- Citations by year
- 2026: 9 · 2025: 12 · 2024: 9
- FWCI
- 0.73
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Metabolites (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- CINECA IRIS Institutional Research Information System (University of Bari Aldo Moro) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- European Project Horizon 2020 “Olive Sound” (820587)
- Topics
- Physical Sciences › Chemistry › Organic Chemistry › Edible Oils Quality and Analysis
- Health Sciences › Medicine › Biochemistry (medical) › Phytochemicals and Antioxidant Activities
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Keywords
- olive oil polyphenols, HDL cholesterol, LDL cholesterol, total cholesterol, lipid metabolism, serum lipids, dietary supplementation, dose-response relationship, LDL oxidation, cardiovascular health, healthy adults, Mediterranean diet, olive oil consumption, dyslipidemia prevention, oxidative stress, endothelial function, blood pressure, coagulation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Olive Oil Polyphenols Improve HDL Cholesterol and Promote Maintenance of Lipid Metabolism: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. https://app.cochat.ai/papers/10.3390/metabo13121187
- The paper
- Zupo, R., Castellana, F., Crupi, P., Desantis, A., Rondanelli, M., Corbo, F., & Clodoveo, M. L. (2023). Olive Oil Polyphenols Improve HDL Cholesterol and Promote Maintenance of Lipid Metabolism: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Metabolites. https://doi.org/10.3390/metabo13121187
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.